Reference : Direct block of SK2 and SK3 current by the sigma agonist 1,3-di-(2-tolyl)guanidine
Scientific congresses and symposiums : Poster
Engineering, computing & technology : Computer science
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/84111
Direct block of SK2 and SK3 current by the sigma agonist 1,3-di-(2-tolyl)guanidine
English
Lamy, Cédric mailto [ > > ]
Moreau, Jacqueline mailto [Université de Liège - ULg > Giga-Neurosciences > Pharmacologie > >]
Dilly, Sébastien mailto [Université de Liège - ULg > Département de pharmacie / Giga-Neurosciences > Chimie pharmaceutique / Pharmacologie > >]
Goodchild, Sam [University of Bristol > Department of Physiology and Pharmacology > > >]
Marrion, Neil [University of Bristol > Department of Physiology and Pharmacology > > >]
Liégeois, Jean-François mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Seutin, Vincent mailto [Université de Liège - ULg > Giga-Neurosciences > Pharmacologie > >]
17-Nov-2008
No
No
International
38th Annual Meeting Neuroscience
du 15 au 19 novembre 2008
SFN
Washington
USA
[en] Sigma receptors are widely distributed in the central nervous system where they modulate neurotransmitter release, receptor function, ionic channel activity and calcium homeostasis. Two subtypes of sigma receptors have been identified (sigma-1 and sigma-2) with different pharmacological profiles, anatomical distribution and physiological functions. 1,3-Di-(2-tolyl)guanidine (DTG) is a sigma-1 and sigma-2 agonist which is widely used to probe the function of these receptors. It has recently been shown that sigma-1 receptor activation reduces the opening of SK channels in the hippocampus. We have observed that DTG (100 µM) reduces the apamin-sensitive afterhyperpolarization (AHP) of dopaminergic neurons within a slice preparation by ~60%, an effect not observed with other sigma agonists. In addition, neither the selective sigma-1 antagonist BD 1047 (30 µM) nor haloperidol (1 µM) blocked the effect of DTG, which suggested that the inhibition of the AHP might result from a direct block of the underlying SK channels.
Whole-cell recordings were made from HEK293 cells transiently transfected with rSK2 or hSK3 cDNA in symmetrical K+ conditions with currents activated by a [Cai] of 1 µM. Expressed SK2 and SK3 channels displayed a classical pharmacology, being blocked by apamin with mean IC50’s of 100 pM and 4 nM, respectively. In contrast, both channel subtypes were blocked with equal sensitivity by N-methyl-laudanosine (NML). DTG inhibited both SK2 and SK3 currents with the same potency (IC50’s were ~30 µM). A mutation that rendered both SK2 and SK3 insensitive to apamin and NML produced a current that was still sensitive to DTG. This direct block of SK channels may be important to consider in relation to the pharmacological effects of this compound.
Giga-Neurosciences, Laboratoire de pharmacologie
First DEI Walloon Region ; Belgian Science Policy ; Fonds de la Recherche Scientifique (Communauté française de Belgique) - F.R.S.-FNRS
Département de pharmacie, Laboratoire de chimie pharmaceutique
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/84111
http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=0bbe4d98-686f-4b55-889a-fdeb8e92d55e&cKey=e7a32682-0fb3-4147-8078-3a42f4d8f105&mKey={AFEA068D-D012-4520-8E42-10E4D1AF7944}

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Abstract-SFN2008.pdfPublisher postprint38.71 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.